Indian benchmark indices ended their third consecutive session in the red on Monday, May 11, with the NSE Nifty 50 closing at 23,815.85, down 360.30 points or 1.49%, and the BSE Sensex settling at 76,015.28, a fall of 1,312.91 points or 1.70%, according to NSE and BSE closing data. The broader market offered no shelter: the Nifty MidCap 100 fell 1.05%, and the SmallCap 100 ended down 1.13%. In three sessions since May 7, the Nifty has dropped over 2%, or 515 points, while the Sensex has shed nearly 1,950 points.
What Actually Triggered Monday’s Crash
Two things. A global one and a domestic one, and together they were a perfect storm.
The sharp correction was primarily triggered by a spike in crude oil prices following renewed geopolitical tensions surrounding the US-Iran situation after the US President expressed dissatisfaction over Iran’s peace proposal. Brent crude surged above $104 per barrel. The rupee came under significant pressure, hitting a new all-time low of 95.32 against the US dollar in early trade amid heightened risk aversion and increased hedging demand.
That was the macro hit. The domestic shock came from Prime Minister Narendra Modi. At a BJP rally in Hyderabad on May 10, Modi appealed to Indians to voluntarily pause gold purchases, especially for weddings, for at least one year, calling it a matter of national responsibility, linking the appeal to the economic strain from India’s ballooning import bill driven by rising crude oil prices and geopolitical tensions in West Asia. Markets reacted immediately. Jewellery, aviation, and consumer discretionary stocks bore the brunt.
Three Stocks That Defined Monday: Titan, IndiGo, SBI — With Verified Numbers
Titan, India’s largest jeweller by sales, fell 6% on the session. Kalyan Jewellers dropped 8% to ₹390.20. Sky Gold fell 9%. Senco Gold was also among the heavily sold jewellery counters, with stocks crashing up to 12% intraday across the gems and jewellery space.
InterGlobe Aviation (IndiGo) was the second-biggest Nifty 50 loser on Monday, falling 4.73% to close at ₹4,309 from its previous close of ₹4,522.70. The logic is straightforward: with crude oil above $105 a barrel, aviation fuel costs are set to surge, squeezing airline margins significantly, and PM Modi’s appeal to postpone non-urgent foreign travel compounded the selling pressure.
SBI fell 4.5%, extending losses after a profit miss. Bharti Airtel dropped 3.79% and Reliance Industries declined 3.47%.
| Stock / Index | May 11 Close | Change (%) | Trigger |
|---|---|---|---|
| Nifty 50 | 23,815.85 | ▼ 1.49% | Broad risk-off |
| Sensex | 76,015.28 | ▼ 1.70% | Iran crude + rupee |
| Titan Company | ₹4,215.50 (approx.) | ▼ ~6–7% | Modi gold austerity call |
| Kalyan Jewellers | ₹390.20 | ▼ 8% | Modi gold austerity call |
| Sky Gold | ₹491.80 | ▼ 9% | Modi gold austerity call |
| IndiGo (InterGlobe) | ₹4,309 | ▼ 4.73% | Crude surge + travel advisory |
| SBI | ₹979.90 | ▼ 4.16% | Profit miss + FII selling |
| Bharti Airtel | ₹1,764.90 | ▼ 3.79% | Broad financial weakness |
| Reliance Industries | — | ▼ 3.47% | Crude / macro |
| Sun Pharma | — | ▲ 1.4% | Defensive buying |
| HUL | — | ▲ 0.9% | Defensive buying |
| Nifty MidCap 100 | — | ▼ 1.05% | Broad selloff |
| Nifty SmallCap 100 | — | ▼ 1.13% | Broad selloff |
Sources: Business Standard, Trading Economics, HDFC Sky, Univest — May 11, 2026
The Angle Everyone Missed: This Was a Policy Shock, Not Just a Crude Story
Crude oil drove the macro headlines. But the disproportionate damage to consumer stocks tells a different, more specific story.
Titan’s jewellery segment had posted approximately 41% year-on-year growth in Q3 FY26, and Kalyan Jewellers’ India operations had grown approximately 42% year-on-year in the same quarter. That kind of growth at that kind of valuation creates enormous downside sensitivity when demand signals shift, even if the policy signal is a voluntary appeal, not a regulation.
India imports nearly 700 to 800 tonnes of gold annually. Gold and crude oil are India’s two largest contributors to the current account deficit. With Brent crude rising from approximately $70 per barrel in early 2026 to over $104 as of May 11, the PM’s appeal specifically targeted the discretionary component of gold demand, particularly the portion driven by weddings.
The broader market selloff gave cover, but the jewellery sector’s 8–12% intraday falls were policy-driven, not just crude-driven. That distinction matters for sector strategy.
One Corner That Held: Pharma’s Relative Resilience
Not everything bled. Sun Pharma and HUL stood out as top gainers, rising 1.4% and 0.9% respectively, while the broader Nifty 50 fell 1.49%. Defensive rotation into pharma during volatile sessions is well-established, but the consistency of this cycle is worth noting.
Indian pharma companies are expected to report aggregate sales growth of 9% year-on-year in Q4 FY26, though EBITDA growth remains muted at roughly 1% due to an elevated base in the US business. The rupee’s depreciation to record lows is actually a tailwind for pharma exporters: dollar-denominated US revenues translate into larger rupee receipts. That dynamic is keeping institutional interest in pharma names alive even as cyclicals get hammered.
Vinod Nair, head of research at Geojit Investments, noted that rising bond yields and persistent FII outflows are likely to keep markets range-bound in the near term. Pharma and FMCG remain the preferred defensive plays in that environment.
Analyst Guidance: Don’t Chase This Market Either Way
Siddhartha Khemka, head of research at Motilal Oswal Financial Services, stated that Indian equities are expected to remain cautious in the near term amid escalating geopolitical tensions, with elevated crude oil prices, rupee weakness, and sustained FII selling likely to keep overall market sentiment subdued.
On technicals, Nifty has approached the lower band of its consolidation range near the 23,800 zone. A decisive breakdown below this level could trigger the next leg of decline toward 23,500, followed by the major support zone around 23,150.
The message from multiple desks is consistent: avoid aggressive index bets in either direction until there is clarity on the Iran situation and the rupee stabilises.
Energy and Metals: Dip or Deterioration?
Energy stocks took collateral damage Monday from the crude surge, counterintuitively, higher crude is a cost, not a benefit, for most of India’s energy consumers and refiners. Metal counters tracked softness in base commodity prices.
The longer-term case for accumulation in quality energy and metal names, those with strong balance sheets, domestic demand exposure, and infrastructure linkage, remains intact. India’s capex pipeline, which the Union Budget 2026 set at ₹12.2 lakh crore, provides a structural demand floor for metals. The short-term volatility is macro noise on top of a multi-year story.
What to Watch Next
Global focus is now shifting to the upcoming meeting between US President Trump and Chinese President Xi Jinping, scheduled in Beijing between May 13 and 15, with discussions expected to span trade, investment, Iran, Taiwan, AI, and rare earth supply chains. That meeting is the single biggest near-term catalyst for global risk sentiment, and by extension, Indian equity direction.
Nifty’s ability to hold 23,800 on a closing basis this week is the domestic technical line in the sand. A confirmed close below it on volume, combined with no de-escalation in the Iran situation, changes the near-term outlook materially.
The rupee at 95.32, a fresh all-time low, is the number to watch daily.
Also Chcek
What Investors Are Actually Searching For
Q: Why did Titan stock fall so much on May 11, 2026?
PM Modi’s May 10 speech at a BJP rally in Hyderabad urged Indians to defer gold purchases for one year, particularly wedding-related buying. Markets interpreted the appeal as a direct headwind to near-term jewellery demand, which triggered swift selling, Titan fell nearly 7%, Kalyan fell 8%, and Sky Gold fell up to 12% intraday. Analysts generally view long-term fundamental damage as limited, given the cultural depth of gold demand in India.
Q: What is Nifty’s support level after Monday’s fall?
Nifty’s immediate support is around the 23,800 zone. A close below that would open a move toward 23,500, with the major support zone at 23,150, according to Aakash Shah at Choice Equity Broking.
Q: Should I buy pharma stocks now amid the market selloff?
Pharma’s relative outperformance is a trend, not a one-day blip. The Nifty Pharma index has gained nearly 1% year-to-date in 2026, compared to an over 7% fall in the Nifty 50 and Sensex over the same period. For investors seeking defensive positioning in a volatile tape, quality large-cap pharma names with US revenue exposure offer a natural hedge, the rupee’s weakness boosts their dollar earnings.
Sources: Business Standard (live market close, May 11, 2026) · Trading Economics (index and stock close data) · BusinessToday / Motilal Oswal / Choice Equity Broking (analyst views, support levels) · HDFC Sky (Nifty 50 top losers detail) · Univest / Nomad Lawyer (jewellery sector and IndiGo selloff) · Zerodha Pulse / NDTV Business (three-session decline data)
This article is for informational purposes only and does not constitute investment advice.
